These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7254280)

  • 21. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
    Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
    In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
    Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
    Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
    N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Source of increased ferritin in neuroblastoma: studies with concanavalin A-sepharose binding.
    Hann HW; Stahlhut MW; Evans AE
    J Natl Cancer Inst; 1986 Jun; 76(6):1031-3. PubMed ID: 3458940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factor in neuroblastoma.
    Evans AE; D'Angio GJ; Propert K; Anderson J; Hann HW
    Cancer; 1987 Jun; 59(11):1853-9. PubMed ID: 3567848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stage IV-S neuroblastoma].
    Mancini AF
    Pediatr Med Chir; 1984; 6(2):209-12. PubMed ID: 6531245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatopathy in patients with stage 4S neuroblastoma].
    Claviez A; Hero B; Schneppenheim R; Berthold F
    Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["As much as possible"--an outdated concept in advanced neuroblastoma?].
    Simon S; Hümmer HP; Carbon R; Klein P
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1056-61. PubMed ID: 9101781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum ferritin in hepatocellular carcinoma.
    Zhou XD; Stahlhut MW; Hann HL; London WT
    Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group.
    Hero B; Kremens B; Klingebiel T; Bender-Götze C; Burdach S; Schrappe M; Berthold F
    Klin Padiatr; 1997; 209(4):196-200. PubMed ID: 9293450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroblastomas contain iron-rich ferritin.
    Iancu TC; Shiloh H; Kedar A
    Cancer; 1988 Jun; 61(12):2497-502. PubMed ID: 3365671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Levels of ferritin in serum of patients with lung cancer].
    Sakowicz A; Kwiek S; Wiatr E
    Pneumonol Alergol Pol; 1991; 59(9-10):38-42. PubMed ID: 1843645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
    Cheung NK; Guo HF; Heller G; Cheung IY
    Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroblastoma in children under than 1 year of age].
    Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
    An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous regression of neuroblastoma.
    Evans AE; Gerson J; Schnaufer L
    Natl Cancer Inst Monogr; 1976 Nov; 44():49-54. PubMed ID: 1030781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].
    Huang CW; Bai L; Cai JJ; Guo W; Lan L
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):466-8. PubMed ID: 12754132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposal and assessment of Japanese tumor node metastasis postsurgical histopathological staging system for neuroblastoma based on an analysis of 495 cases.
    Nakagawara A; Morita K; Okabe I; Uchino J; Ohi R; Iwafuchi M; Matsuyama S; Nagashima K; Takahashi H; Nakajo T
    Jpn J Clin Oncol; 1991 Feb; 21(1):1-7. PubMed ID: 2067117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
    Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
    Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferritin in neuroblastoma. Impact of tumor load and blood transfusions.
    Potaznik D; de Sousa M; Helson L; Bagin R; Groshen S; Bhalla RB
    Cancer Invest; 1985; 3(4):327-38. PubMed ID: 4027755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of isoferritins from tumour and non-tumour tissues on E-rosette formation.
    Hann HW; Stahlhut MW; Chung LC
    Lancet; 1984 Jan; 1(8367):43. PubMed ID: 6140361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.